Evidence map›Paper›PMID 33522795›Full record

ArticleACS chemical neuroscience2021

Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters.

Shinji Urata, Junki Maruyama, Megumi Kishimoto-Urata, Rachel A Sattler, Rebecca Cook, Nantian Lin, Tatsuya Yamasoba, Tomoko Makishima, Slobodan Paessler

Open access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mechanisms of COVID-19-associated olfactory dysfunction.Neuropathology and applied neurobiology · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Shinji UrataDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Junki MaruyamaDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Megumi Kishimoto-UrataDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Rachel A SattlerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Rebecca CookDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Nantian LinDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
Tatsuya YamasobaDepartment of Otolaryngology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Tomoko MakishimaDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, Texas 77555, United States.ORCID 0000-0003-3397-6395
Slobodan PaesslerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, United States.
The University of Texas Medical Branch at Galveston · USThe University of Tokyo · JP

Funding

Sequelae of Lassa FeverR01AI129198 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PAESSLER, SLOBODAN · 2018 to 2022
$3.9M
NIAID NIH HHS R01 AI129198
6 · The paper itself

Abstract

Olfactory dysfunction is one of the most frequent and specific symptoms of coronavirus disease 2019 (COVID-19). Information on the damage and repair of the neuroepithelium and its impact on olfactory function after COVID-19 is still incomplete. While severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the ongoing worldwide outbreak of COVID-19, little is known about the changes triggered by SARS-CoV-2 in the olfactory epithelium (OE) at the cellular level. Here, we report profiles of the OE after SARS-CoV-2 infection in golden Syrian hamsters, which is a reliable animal model of COVID-19. We observed severe damage in the OE as early as 3 days postinoculation and regionally specific damage and regeneration of the OE within the nasal cavity; the nasal septal region demonstrated the fastest recovery compared to other regions in the nasal turbinates. These findings suggest that anosmia related to SARS-CoV-2 infection may be fully reversible.

Indexed as

RegenerationSARS-CoV-2AnimalsAnosmiaCOVID-19Disease Models, AnimalMesocricetusNasal CavityNasal SeptumOlfactory MucosaOlfactory Receptor NeuronsOrgan SizeTurbinatesanosmiaCOVID-19olfactory dysfunctionolfactory epitheliumSARS-CoV-2

Identifiers

PMID33522795
PMCPMC7874468
OpenAlexW3127409556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.